hotspot -WSS

hotspot

author：explore 2025-09-06 04:15:36 - browse：64

Stain of a biopsy specimen of a rhabdoid tumor -- health coverage from STAT — Stain of a biopsy specimen of a rhabdoid tumor. Wikimedia Commons

Most targeted cancer drugs work like tranquilizer darts, snaring an overzealous gene that has spurred the cell into murderously rapid growth.

But many tumors don’t have a hyperactive gene. Like the mayhem in “Cat in the Hat,” they are enabled by parental absence. They grow because the genes that are meant to provide discipline, guiding the activity of other genes or self-destructing a cell whose DNA is too damaged, are broken or missing.

These tumors have bedeviled researchers for decades. Restoring or fixing a protein is far harder than breaking it. And that’s bad news for humanity: Cancer is far more likely to be caused by such “tumor-suppressor” genes than by one gene run amok.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Hospitals look to new technology to keep health care workers safe

hotspot

focus

WSS

New research casts further doubt on a common procedure used with IVF

Wegovy, Zepbound and weight loss drugs that preserve muscle

Lecanemab for Alzheimer's is coming. Is the health system ready?

Bulgari apologizes to China for listing Taiwan as a country after online backlash

What to know about OceanGate, the company behind the missing Titanic submersible

It's time to get medical device identifiers over the finish line

hotspot

hotspot

focus

23andMe had bad news about my health. I wish a person had delivered it

Lecanemab for Alzheimer's is coming. Is the health system ready?

Medicare details structure of new drug price negotiation program

HCA discloses massive data breach affecting 11 million patients

Drug repurposing or repositioning? The language matters

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

Hollywood unions extend contract negotiations for actors

Surge of respiratory disease in China has likely explanation

Heart attack and stroke risk calculators need revising

Gain of function research would be limited under House proposal

Wikipedia

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Palantir health business leans on meeting customers’ needs

CRISPR pioneers react to Casgevy, first gene

U.K. considers world's first use of meningitis vaccine to address gonorrhea

In key trial, Verve's treatment lowers cholesterol levels in patients

HCA discloses massive data breach affecting 11 million patients

hotspot

hotspot

focus

hotspot